Santhosh Mathews is a Cardiology physician affiliated with Bradenton Neurology. OpenAlex indexes 22 publications with 451 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
316 Manatee Ave W
Bradenton, FL 342058805
Telephone
941-748-2277Registry record last updated 21 Jul 2022.
Industry payments
49 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Penumbra, Inc.Program year2025112 payments$156,443openpaymentsdata.cms.gov ↗
- Reflow Medical IncProgram year202538 payments$22,988openpaymentsdata.cms.gov ↗
- Cagent Vascular INCProgram year202512 payments$11,893openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
75.8%Statin16.7%Rosuvastatin Calcium52%Atorvastatin Calcium40%Simvastatin4%Pravastatin Sodium4%Part D≥242 patientsBeta blocker16%Metoprolol Succinate50%Carvedilol26%Metoprolol Tartrate20%Atenolol3%Labetalol Hcl1%Part D<11 patients+ 20 more classes in this area
Blood & clotting
21.1%P2Y12 inhibitor11.5%Clopidogrel98%Brilinta2%Part D<11 patientsFactor Xa inhibitor7.1%Eliquis71%Xarelto30%Part D≥114 patients+ 3 more classes in this area
Metabolism & gastrointestinal
2.6%SGLT2 inhibitor0.9%Jardiance100%Part D≥15 patientsProton pump inhibitor0.8%Pantoprazole Sodium100%Part D≥23 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- TCT-1034 Comparison of Novel ClotIQ Quantification Software to Traditional Thrombus Evaluation Methods for Thrombectomy Procedure Planning
Journal of the American College of Cardiology
2025 - Consensus Statement on the Management of Nonthrombotic Iliac Vein Lesions From the VIVA Foundation, the American Venous Forum, and the American Vein and Lymphatic Society
Circulation Cardiovascular Interventions
2024 - Sustained Mechanical Aspiration Thrombectomy for High Thrombus Burden Coronary Vessel Occlusion: The Multicenter CHEETAH Study
Circulation Cardiovascular Interventions
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”